Biologics News

Patients with knee osteoarthritis who underwent high tibial osteotomy combined with intra-articular pure platelet-rich plasma had improved clinical and functional outcomes during the first postoperative year, according to published results.

National Doctors’ Day marks the anniversary of the first use of general anesthesia in surgery by Crawford W. Long, MD, on March 30, 1842. To celebrate, Healio Orthopedics revisits stories that reflect on the impact of orthopedic surgeons.

CHICAGO — Platelet-rich plasma injections provided pain relief for osteoarthritic knees for up to 1 year after treatment, based on a systematic literature review presented here.

Autologous stromal vascular fraction treatment yielded “acceptable clinical states” in most patients with knee osteoarthritis at 5 years, according to published results.

Compared with conservative treatment, hematoma aspiration combined with platelet-rich plasma injection may shorten return to play and reduce recurrence rate among athletes with grade 2 hamstring strains, according to published results.

Bonalive Biomaterials Ltd. has been granted FDA breakthrough device designation for its Bonalive orthopedics granules, a bone graft substitute designed to protect against microbial infection, according to a press release.

Published results showed osteochondral allograft glenoid resurfacing combined with humeral hemiarthroplasty yielded early failure rates among patients with glenohumeral osteoarthritis.

Published results showed patients undergoing high tibial osteotomy combined with a human umbilical cord blood-derived mesenchymal stem cell cartilage regeneration procedure may experience improved clinical outcomes and joint space width.

Just a few weeks ago, my identical twin brother, Mike, lost his nearly 5-year battle with cancer. My brother was my hero, and he faced the suffering of a terminal illness with extraordinary grit and positivity.

TAMPA, Fla. — Among patients who underwent osteochondral allograft transplantation, failure of the procedure was not linked to mismatched donor-recipient blood types, a researcher said at the Orthopaedic Research Society Annual Meeting.